Literature DB >> 18155801

Enhancing intestinal drug solubilisation using lipid-based delivery systems.

Christopher J H Porter1, Colin W Pouton, Jean F Cuine, William N Charman.   

Abstract

Lipid-based delivery systems are finding increasing application in the oral delivery of poorly water-soluble, lipophilic drugs. Whilst lipidic dose forms may improve oral bioavailability via several mechanisms, enhancement of gastrointestinal solubilisation remains argueably the most important method of absorption enhancement. This review firstly describes the mechanistic rationale which underpins the use of lipid-based delivery systems to enhance drug solubilisation and briefly reviews the available literature describing increases in oral bioavailability after the administration of lipid solution, suspension and self-emulsifying formulations. The use of in vitro methods including dispersion tests and more complex models of in vitro lipolysis as indicators of potential in vivo performance are subsequently described, with particular focus on recent data which suggests that the digestion of surfactants present in lipid-based formulations may impact on formulation performance. Finally, a series of seven guiding principles for formulation design of lipid-based delivery systems are suggested based on an analysis of recent data generated in our laboratories and elsewhere.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18155801     DOI: 10.1016/j.addr.2007.10.014

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  100 in total

1.  Spontaneous emulsification of nifedipine-loaded self-nanoemulsifying drug delivery system.

Authors:  Yotsanan Weerapol; Sontaya Limmatvapirat; Mont Kumpugdee-Vollrath; Pornsak Sriamornsak
Journal:  AAPS PharmSciTech       Date:  2014-10-31       Impact factor: 3.246

2.  The studies of phase equilibria and efficiency assessment for self-emulsifying lipid-based formulations.

Authors:  Ahmad Abdul-Wahhab Shahba; Kazi Mohsin; Fars Kaed Alanazi
Journal:  AAPS PharmSciTech       Date:  2012-03-23       Impact factor: 3.246

3.  A new in vitro lipid digestion - in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations.

Authors:  Matthew F Crum; Natalie L Trevaskis; Hywel D Williams; Colin W Pouton; Christopher J H Porter
Journal:  Pharm Res       Date:  2015-12-24       Impact factor: 4.200

Review 4.  Oral bioavailability: issues and solutions via nanoformulations.

Authors:  Kamla Pathak; Smita Raghuvanshi
Journal:  Clin Pharmacokinet       Date:  2015-04       Impact factor: 6.447

Review 5.  Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.

Authors:  Angel Tan; Shasha Rao; Clive A Prestidge
Journal:  Pharm Res       Date:  2013-06-18       Impact factor: 4.200

Review 6.  Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations.

Authors:  Cheng Loong Ngan; Azren Aida Asmawi
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

7.  Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.

Authors:  Naveen Chella; Bhaskar Daravath; Dinesh Kumar; Rama Rao Tadikonda
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

8.  Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation.

Authors:  Ryusuke Takano; Kentaro Furumoto; Koji Shiraki; Noriyuki Takata; Yoshiki Hayashi; Yoshinori Aso; Shinji Yamashita
Journal:  Pharm Res       Date:  2008-06-17       Impact factor: 4.200

9.  Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668.

Authors:  Joel M Reid; Chad A Walden; Rui Qin; Katie L Allen Ziegler; John L Haslam; Roger A Rajewski; Roger Warndahl; Cindy L Fitting; Daniel Boring; Eva Szabo; James Crowell; Marjorie Perloff; Ling Jong; Brent A Bauer; Sumithra J Mandrekar; Matthew M Ames; Paul J Limburg
Journal:  Cancer Prev Res (Phila)       Date:  2011-03

10.  Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent.

Authors:  Carol E Green; Robert Swezey; James Bakke; Walter Shinn; Anna Furimsky; Naveen Bejugam; Gita N Shankar; Ling Jong; Izet M Kapetanovic
Journal:  Cancer Chemother Pharmacol       Date:  2010-07-10       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.